Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

295.19
+3.741.28%
Post-market: 295.190.00000.00%19:38 EDT
Volume:887.56K
Turnover:262.16M
Market Cap:14.09B
PE:-60.47
High:298.18
Open:291.78
Low:289.07
Close:291.45
52wk High:299.32
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:1.02
T/O Rate:1.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.96
PE(LYR):-101.36

Loading ...

Charles River Labs is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Aug 06

JPMorgan Upgrades Charles River Laboratories International to Overweight From Neutral, Adjusts PT to $310 From $180

MT Newswires Live
·
Aug 06

U.S. Research Roundup-Caterpillar, Eli Lilly, McKesson

Reuters
·
Aug 06

Charles River Laboratories International, Inc. : JP Morgan Raises to Overweight from Neutral; Raises Target Price to $310 from $180

THOMSON REUTERS
·
Aug 06

Sector Update: Healthcare

MT Newswires Live
·
Aug 06

Charles River price target raised to $300 from $260 at Evercore ISI

TIPRANKS
·
Aug 06

Charles River Says Biotech Demand Is Back — Bookings Hit Four-Year High

Benzinga Earnings
·
Aug 06

Analysts Are Bullish on These Healthcare Stocks: Charles River Labs (CRL), Zymeworks (ZYME)

TIPRANKS
·
Aug 06

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Aug 06

Early notable gainers among liquid option names on August 5th

TIPRANKS
·
Aug 05

Charles River Laboratories International up Nearly 12%, on Track for Highest Close Since April 2024

Dow Jones
·
Aug 05

Movement Alert|Charles River Laboratories Rises 8.32% in Regular Trading, Q2 Earnings Beat Expectations with Full-Year Guidance Raised

Market Focus
·
Aug 05

Stock Track | Charles River Laboratories Soars 13.62% Intraday on Q2 Earnings Beat and Raised Profit Forecast

Stock Track
·
Aug 05

Charles River Laboratories International, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Charles River Exec Says Well Positioned to Support Our Acquisition Strategy, We'd Love to be Able to Add a Couple Additional Companies to Our Portfolio - Conf Call

THOMSON REUTERS
·
Aug 05

Charles River Exec Says There Will Never be a Nams Business for Charles River, Will Always be a Safety Assessment Business Where We're Integrating Nams into Our Safety Assessment Workflows - Conf Call

THOMSON REUTERS
·
Aug 05

Charles River Exec Says Q3 Adj EPS Expected at $2.90-$3.00 - Conf Call

THOMSON REUTERS
·
Aug 05

Charles River Exec Says Continue to Expect Lower Volumes for Research Models in North America, Spending from Academic and Government Clients Has Been Constrained by Flat Nih Budgets and Slower Grant Processing - Conf Call

THOMSON REUTERS
·
Aug 05

U.S. Stocks on the MOVE-Cencora, Charles River, Twist Bioscience

Reuters
·
Aug 05

Stock Track | Charles River Laboratories Soars 8.15% in Pre-Market on Q2 Earnings Beat and Raised Guidance

Stock Track
·
Aug 05